Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

MLA

Boero, Silvia, et al. “Analysis of in Vitro ADCC and Clinical Response to Trastuzumab: Possible Relevance of FcγRIIIA/FcγRIIA Gene Polymorphisms and HER-2 Expression Levels on Breast Cancer Cell Lines.” Journal of Translational Medicine, vol. 13, no. 1, Oct. 2015, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12967-015-0680-0.

APA

Boero, S., Morabito, A., Banelli, B., Cardinali, B., Dozin, B., Lunardi, G., Piccioli, P., Lastraioli, S., Carosio, R., Salvi, S., Levaggi, A., Poggio, F., D’Alonzo, A., Romani, M., Del Mastro, L., Poggi, A., & Pistillo, M. P. (2015). Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. Journal of Translational Medicine, 13(1), 1–14. https://doi.org/10.1186/s12967-015-0680-0

Chicago

Boero, Silvia, Anna Morabito, Barbara Banelli, Barbara Cardinali, Beatrice Dozin, Gianluigi Lunardi, Patrizia Piccioli, et al. 2015. “Analysis of in Vitro ADCC and Clinical Response to Trastuzumab: Possible Relevance of FcγRIIIA/FcγRIIA Gene Polymorphisms and HER-2 Expression Levels on Breast Cancer Cell Lines.” Journal of Translational Medicine 13 (1): 1–14. doi:10.1186/s12967-015-0680-0.